New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 28, 2014
10:14 EDTSHPG, VRX, AGNShire climbs after analyst argues Allergan could make bid
Shares of drug maker Shire (SHPG) are climbing after research firm Piper Jaffray predicted that Allergan (AGN) could look to merge with Shire as its best defense to fend off Valeant (VRX). WHAT'S NEW: Allergan's best hope for fending off Valeant's hostile takeover bid would be to merge with Shire, wrote Piper Jaffray analyst David Amsellem in a note to investors earlier today. Moreover, an acquisition of Shire would raise Allergan profits significantly over the near-term and long-term, contended the analyst. The deal could increase Allergan's profit by 50% or higher starting next year, according to Amsellem's estimates. Additionally, the deal would create a company with a strong drug pipeline, contended the analyst, who kept a Neutral rating on Allergan. WHAT'S NOTABLE: A number of firms, including JPMorgan, Sterne Agee, and BMO Capital, predicted today that Valeant would raise its bid for Allergan. PRICE ACTION: In early trading, Shire gained 2.7% to $166.86, Allergan was little changed at $168.60, and Valeant was fractionally higher at $134.50.
News For SHPG;AGN;VRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 27, 2015
19:14 EDTVRXOn The Fly: After Hours Movers
Subscribe for More Information
18:27 EDTVRXSalix receives FDA Approval of Xifaxan for treatment of IBS-D
Subscribe for More Information
16:59 EDTVRXFDA approves Salix-marketed Xifaxan
The FDA approved Viberzi and Xifaxan, two new treatments, manufactured by two different companies, for irritable bowel syndrome with diarrhea, or IBS-D, in adult men and women. Xifaxan is marketed by Salix Pharmaceuticals, which was acquired by Valeant Pharmaceuticals. Reference Link
May 26, 2015
08:14 EDTSHPGBoston Biotech Conferences to hold a conference
Subscribe for More Information
May 21, 2015
19:54 EDTVRXValeant to expand Canadian presence in coming years, Globe and Mail says
Subscribe for More Information
07:37 EDTSHPGPfizer replaces AbbVie as top global pharma pick at Jefferies
Subscribe for More Information
May 20, 2015
06:37 EDTVRXSources: Valeant in talks to buy Amoun Pharmaceutical, Bloomberg reports
Subscribe for More Information
06:32 EDTVRXValeant CEO sees quintupling in Asia sales by 2020, Reuters reports
Subscribe for More Information
May 15, 2015
17:15 EDTVRXPaulson & Co. gives quarterly update on stakes
Subscribe for More Information
17:08 EDTVRXSoros Fund gives quarterly update on stakes
Subscribe for More Information
17:03 EDTVRXPershing Square gives quarterly update on stakes
Subscribe for More Information
11:08 EDTSHPGOmega Advisors gives quarterly update on stakes
NEW STAKES: Targa Resources (TRGP), Targa Resources Partners (NGLS), Humana (HUM), Dow Chemical (DOW), and Twenty-First Century Fox (FOXA). INCREASED STAKES: Kinder Morgan (KMI), Chimera Investment Corporation (CIM), AerCap Holdings (AER), Shire (SHPG), and KKR & Co. (KKR). DECREASED STAKES: eBay (EBAY), Altisource Portfolio Solutions (ASPS), Caesars Entertainment (CZR), Navient (NAVI), and TerraForm Power (TERP). LIQUIDATED STAKES: HCA Holdings (HCA), Gilead (GILD), Cabot Oil & Gas (COG), and Apple (AAPL).
10:55 EDTVRXJANA Partners gives quarterly update on stakes
Subscribe for More Information
10:29 EDTAGNAmerican Urological Association to hold an annual meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use